About hc1

hc1® is the bioinformatics leader in precision testing and prescribing. Dedicated to improving lives with high-value care, hc1 delivers solutions to laboratories, health systems, and health plans that ensure each patient gets the right test and the right prescription.  

The hc1 High-Value Care Platform® utilizes cloud computing and advanced machine learning to integrate, normalize, and enrich the largest repository of live, homogenized laboratory orders and results, with more than 19B integrated results across 160M unique individuals. 

By leveraging our massive scale and cloud-native infrastructure, our expert team of clinicians, technologists, and data scientists engaged with our coalition partners to rapidly deliver this critical dashboard to assist in mitigating the spread of COVID-19.  

To learn more about hc1, please visit hc1.com.
 


 

Some of the highest volume labs in the United States have joined hc1 to deliver the data contained in this dashboard. Results for more than 20,000 ordering locations are included.

Contributing Partners

The CV19 Lab Testing Dashboard powered by hc1 displays testing insights based on the data supplied by Lab Coalition members across the United States. While additional testing is occurring beyond what is represented on this dashboard, these insights are drawn from the ‘live data feed’ of thousands of participating lab locations. Therefore, the dashboard offers near real-time information toward understanding the pandemic spread of COVID-19 as defined by the number of tests performed and the results of those tests (i.e., detected, not detected, inconclusive.) All other Clinical Laboratory organizations performing COVID-19 testing that are not currently contributing to the CV19 Lab Testing Dashboard are invited* to participate in this coalition. With your COVID-19 test data added, the resulting dashboard will become even more informative. This site uses technology supported in Chrome, Edge, Firefox, and Safari. Other browsers may not be compatible.

© 2011-2020 hc1. All rights reserved.